BIOMARKERS FOR TRIPLE-NEGATIVE BREAST CANCER

摘要

Biomarkers useful in the therapy, diagnosis, analysis, and prognostication of triple-negative breast cancer are provided. The biomarkers show low expression in tumors that present a high risk of relapse. The biomarkers in question are CIITA, CD74, HLA-DPA1, HLA-DPB1, HLA-DPB2, HLA-DQA1, HLA-DRB1, HLA-DRB5, HLA-DRB6, CTSH, NCOA1, CD1E, FCGRT, KRT14, LPAR5, FGD3, VAMP2, LRRK2, MBNL1, NTRK3, POLR3GL, PTGDS, SH3BGRL, and TOX.